These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29856896)

  • 1. Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease.
    Munsterman ID; Kendall TJ; Khelil N; Popa M; Lomme R; Drenth JPH; Tjwa ETTL
    Histopathology; 2018 Oct; 73(4):612-621. PubMed ID: 29856896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.
    Yilmaz Y; Eren F
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):43-46. PubMed ID: 30134384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
    Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
    Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis.
    Lachowski D; Cortes E; Rice A; Pinato D; Rombouts K; Del Rio Hernandez A
    Sci Rep; 2019 May; 9(1):7299. PubMed ID: 31086224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ASSESSMENT OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS FOR NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE].
    Livzan MA; Lapteva IV; Krolevets TS
    Eksp Klin Gastroenterol; 2016; (7):25-31. PubMed ID: 30284418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury.
    Park SY; Shin HW; Lee KB; Lee MJ; Jang JJ
    J Korean Med Sci; 2010 Apr; 25(4):570-6. PubMed ID: 20358000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.
    Xu T; Pan L; Li L; Hu S; Zhou H; Yang C; Yang J; Li H; Liu Y; Meng X; Li J
    J Cell Mol Med; 2020 Jul; 24(13):7127-7140. PubMed ID: 32463570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors.
    Latronico T; Mascia C; Pati I; Zuccala P; Mengoni F; Marocco R; Tieghi T; Belvisi V; Lichtner M; Vullo V; Mastroianni CM; Liuzzi GM
    Int J Mol Sci; 2016 Mar; 17(4):455. PubMed ID: 27023536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
    Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
    Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitors of metalloproteinases in liver fibrosis.
    Iredale JP
    Int J Biochem Cell Biol; 1997 Jan; 29(1):43-54. PubMed ID: 9076940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease.
    Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L
    Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-dependent expression of fibrogenic markers in alcohol-related liver disease.
    Sørensen MD; Thiele M; Krag A; Daniels SJ; Leeming DJ; Karsdal M; Detlefsen S
    Pathol Res Pract; 2022 Mar; 231():153798. PubMed ID: 35180651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation.
    Dechêne A; Sowa JP; Gieseler RK; Jochum C; Bechmann LP; El Fouly A; Schlattjan M; Saner F; Baba HA; Paul A; Dries V; Odenthal M; Gerken G; Friedman SL; Canbay A
    Hepatology; 2010 Sep; 52(3):1008-16. PubMed ID: 20684020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Leukocytes and Plasma of Children with Nonalcoholic Fatty Liver Disease.
    Trojanek JB; Michałkiewicz J; Grzywa-Czuba R; Jańczyk W; Gackowska L; Kubiszewska I; Helmin-Basa A; Wierzbicka-Rucińska A; Szalecki M; Socha P
    Mediators Inflamm; 2020; 2020():8327945. PubMed ID: 32963496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
    Becher N; Hein M; Uldbjerg N; Danielsen CC
    Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.